Premium
Q BioMed Inc (CE) (QBIO)
USOTC
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Q BioMed Announces Strontium89 Initial Uptake and Momentum in US and EuropeSeveral International Market Authorisations Expected in Q4 Expanding Access to South and Central America and...
Q BioMed Announces Initiation of GMP Production of Novel COVID-19 Therapeutic for Clinical Trial Program COVID-19 clinical trial planned for Q1 2021 supported by Canadian...
Q BioMed Announces Strontium89 will be available as of September 2020 through Named Patient Program for Bone Metastases Pain Palliation in EU and Rest of World Named Patient...
FORT LEE, NJ -- March 19, 2019 -- InvestorsHub NewsWire -- GD Entertainment And Technology (OTC: GDET) (“GDET” or the “Company”) today announced CEO Anil Idnani was...
Four Trending Stocks Leading Biotech Sector on Heels of Latest R&D and Innovative Drug Therapy Advancements Coral Springs, FL -- July 27, 2016 -- InvestorsHub...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 61846 | 1.0E-6 | CS |
| 4 | -9.9E-5 | -99 | 0.0001 | 0.0001 | 1.0E-6 | 32115 | 3.626E-5 | CS |
| 12 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 162798 | 9.092E-5 | CS |
| 26 | -9.0E-6 | -90 | 1.0E-5 | 0.01 | 1.0E-6 | 109229 | 9.546E-5 | CS |
| 52 | -0.000499 | -99.8 | 0.0005 | 0.0405 | 1.0E-6 | 71207 | 0.00010809 | CS |
| 156 | -0.449999 | -99.9997777778 | 0.45 | 0.575 | 1.0E-6 | 643861 | 0.02655962 | CS |
| 260 | -1.814999 | -99.9999449036 | 1.815 | 3.75 | 1.0E-6 | 391018 | 0.17415111 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
